PubRank

Bin T Teh

Author PubWeight™ 68.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Signatures of mutation and selection in the cancer genome. Nature 2010 9.75
2 Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005 7.66
3 Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery 2008 2.26
4 VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 2006 2.03
5 Regulation of endocytosis via the oxygen-sensing pathway. Nat Med 2009 2.00
6 Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol 2009 1.84
7 Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol 2008 1.70
8 Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study. Mol Cancer Ther 2010 1.70
9 Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein. J Biol Chem 2005 1.64
10 The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell-cycle progression in malignant bladder cancer cells in vitro and in vivo. Clin Cancer Res 2013 1.62
11 Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res 2004 1.47
12 The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res 2008 1.33
13 Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol 2007 1.22
14 Functional importance of Dicer protein in the adaptive cellular response to hypoxia. J Biol Chem 2012 1.15
15 Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinoma. Clin Cancer Res 2005 1.09
16 Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res 2004 1.06
17 Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics 2010 1.06
18 Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci U S A 2011 1.05
19 Prospective clinical trial of preoperative sunitinib in patients with renal cell carcinoma. J Urol 2010 1.04
20 Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder. BMC Med Genomics 2010 1.03
21 Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer. Clin Cancer Res 2009 0.98
22 Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma. Hum Pathol 2006 0.98
23 Folliculin interacts with p0071 (plakophilin-4) and deficiency is associated with disordered RhoA signalling, epithelial polarization and cytokinesis. Hum Mol Genet 2012 0.98
24 Maximizing RNA yield from archival renal tumors and optimizing gene expression analysis. J Biomol Screen 2009 0.94
25 Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma. J Clin Endocrinol Metab 2008 0.94
26 Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 2004 0.93
27 Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Cancer Res 2011 0.90
28 The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA. Mol Carcinog 2010 0.89
29 Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeek). Clin Cancer Res 2005 0.89
30 CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors. Endocr Relat Cancer 2010 0.88
31 Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma. Anal Quant Cytol Histol 2006 0.88
32 Elucidation of the molecular signatures of renal cell carcinoma by gene expression profiling. J Med Invest 2006 0.87
33 Kinase targets in renal-cell carcinomas: reassessing the old and discovering the new. Lancet Oncol 2010 0.87
34 Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma. Mod Pathol 2011 0.86
35 Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma. Am J Clin Pathol 2005 0.85
36 Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesis. Cancer Biol Ther 2008 0.85
37 Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma. Am J Surg Pathol 2004 0.85
38 Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma. Am J Pathol 2011 0.84
39 Gene expression profiling of renal cell carcinoma and clinical implications. Urology 2005 0.84
40 Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma. Am J Clin Pathol 2006 0.83
41 Molecular targets on the horizon for kidney and urothelial cancer. Nat Rev Clin Oncol 2013 0.82
42 Gene expression profiling of renal cell carcinoma and its implications in diagnosis, prognosis, and therapeutics. Adv Cancer Res 2003 0.82
43 Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab 2014 0.81
44 From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue. Int J Oncol 2006 0.80
45 Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism. Am J Pathol 2002 0.80
46 Spectral karyotyping of sarcomas and fibroblasts derived from Ink4a/Arf-deficient mice reveals chromosomal instability in vitro. Int J Oncol 2005 0.80
47 A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma. Mutat Res 2008 0.79
48 Glypican 3 overexpression in primary and metastatic Wilms tumors. Virchows Arch 2014 0.78
49 Gene profiling suggests a common evolution of bladder cancer subtypes. BMC Med Genomics 2013 0.77
50 Dual KS: Defining Gene Sets with Tissue Set Enrichment Analysis. Cancer Inform 2010 0.76
51 Microarray gene expression profiling using core biopsies of renal neoplasia. Am J Transl Res 2009 0.76
52 HRPT2 and parathyroid cancer. Lancet Oncol 2004 0.75